Repository logo
 

Dietetics, Nutrition and Biological Sciences

Permanent URI for this collectionhttps://eresearch.qmu.ac.uk/handle/20.500.12289/23

Browse

Author: search.filters.author.Fyfe, LornaSubject: search.filters.subject.Honey

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Honey combination therapies for skin and wound infections: A systematic review of the literature
    (Dove Medical Press, 2020-11-24) McLoone, Pauline; Tabys, Dina; Fyfe, Lorna
    Topical application of medical grade honey is recommended for the clinical management of wound infections. The suitability of honey as a wound healing agent is largely due to its antibacterial activity, immune modulatory properties, and biocompatibility. Despite the usefulness of honey in wound healing, chronic wound infections continue to be a global problem requiring new and improved therapeutic interventions. Several recent studies have investigated the effects of combining honey with other therapies or agents with the aim of finding more efficacious treatments. In this systematic review, the database PubMed was used to carry out a search of the scientific literature on the combined effects of honey and other therapies on antimicrobial activity and wound and skin healing. The search revealed that synergistic or additive antimicrobial effects were observed in vitro when honey was combined with antibiotics, bacteriophages, antimicrobial peptides, natural agents e.g. ginger or propolis and other treatment approaches such as the use of chitosan hydrogel. Outcomes depended on the type of honey, the combining agent or treatment and the microbial species or strain. Improved wound healing was also observed in vivo in mice when honey was combined with laser therapy or bacteriophage therapy. More clinical studies in humans are required to fully understand the effectiveness of honey combination therapies for the treatment of skin and wound infections.
  • Thumbnail Image
    Item
    Inhibition and changes in antibiotic sensitivity of bacteria cultured aerobically and anaerobically in four different medicinal honeys
    (eScientific, 2020-03-27) Klein, Juan-Pablo; Graves-Morris, Katherine; Coyle, Shirley; Fyfe, Lorna
    The growing prevalence of bacterial antibiotic resistance has led to a rediscovery of the antimicrobial properties of honey. This study investigated the antibacterial activity in aerobic and anaerobic conditions, the effect on bacterial antibiotic sensitivity, and the composition of four medical-grade honeys Medihoney®, Comvita® Antibacterial Wound Gel™, Revamil® gel, and Surgihoney™RO®.A broth assay was used to assess the antibacterial activity of the honeys against Staphylococcus aureus and Pseudomonas aeruginosa in aerobic and anaerobic conditions. A disk diffusion test was used to investigate the effect of exposure to a subinhibitory concentration of the honeys to the sensitivity of bacteria to a range of antibiotics. The composition of each honey was characterised by measuring: sugar content, pH, hydrogen peroxide activity, total polyphenolic content and antioxidant capacity.The honeys differed widely in antibacterial activity. Medihoney® was the most effective reducing the growth of both bacteria to < 1 compared to 9 log10 cfu/mL in the growth controls at all tested concentrations. Revamil® gel was the least active of the honeys only having a negligible effect on bacterial growth at the 25% honey concentration. All honeys were equally or more active in anaerobic conditions than in aerobic conditions. The polyphenolic content may influence the activity of honey. Various honey-antibiotic combinations were identified that enhanced antibiotic sensitivity in bacteria. More research is needed to clarify the role of polyphenols in honey activity and further explore the potential synergies between the honeys and antibiotics.
  • Thumbnail Image
    Item
    Influence of Subinhibitory Concentrations of Honey on Toxic Shock Syndrome Toxin -1 (TSST-1) Production by Two Strains of Staphylococcus Aureus
    (Horizon Research Publishing, 2015-05) Okoro, P.; Coyle, S.; Fyfe, Lorna
    Antibiotic resistant bacteria are a worldwide health concern and it is essential to develop new antimicrobial agents to kill these bacteria and to reduce the use of antibiotics. Staphyloccus aureus (S.aureus) an important medical pathogen is responsible for many wound infections and up to 25% of all strains produce the toxic shock syndrome toxin (TSST-1) which stimulates the release of inflammatory cytokines which cause fever and shock. Here we report on the inhibition of two penicillin resistant TSST-1 producing strains of S.aureus by seven different honeys. Bacterial growth was reduced after 24 hours at 37oC, from 10.0 log 10 in the TSB growth control to less than 1.0 log 10 in Highland, Chilean and Manuka honey. TSST-1 production was reduced from 256ng/ml in the TSB growth control to less than 30 ng/ml in sub inhibitory concentrations of all honeys.